A combination treatment has shown promise for treating a rare blood disease, according to a clinical trial published in the ...
With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.
New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback